# Combination Chemotherapy in Treating Women With Stage III Breast Cancer

> **NCT00002696** · PHASE3 · SUSPENDED · sponsor: **Grupo Oncologico Cooperativo del Sur**

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** CAF regimen
- **DRUG:** CMF regimen
- **DRUG:** cyclophosphamide
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** fluorouracil
- **DRUG:** methotrexate
- **PROCEDURE:** adjuvant therapy
- **PROCEDURE:** conventional surgery
- **PROCEDURE:** neoadjuvant therapy
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00002696
- **Lead sponsor:** Grupo Oncologico Cooperativo del Sur
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 1995-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2013-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002696, "Combination Chemotherapy in Treating Women With Stage III Breast Cancer". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00002696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*